Form 424B5 Adamas Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Adamas Pharma (ADMS) Lower on $50M Stock Offering
December 3, 2019 5:58 PM ESTAdamas Pharma (NASDAQ: ADMS) is lower after the company filed a prospectus covering $50 million in common stock. Shares will be offered through Cowen.
... More


